Developer docs
API playgroundTry for free, no card

Search company profiles

Biosystems

Full company profile

uuid02lxc1b

Namestring
Biosystems
Legal namestring
BioSystems S.A.
Company typeenum
Private
Founded yearint
1981
Descriptiontext

BioSystems S.A. is a Barcelona-headquartered biotechnology company founded in 1981 that designs, develops, manufactures, and markets analytical instruments and reagent kits for in vitro diagnostics (IVD) and selected industrial applications. The portfolio is organized into five solution segments: Clinical Analysis (Biochemistry Systems using the BA400, BA200, A15, and A15S analysers together with clinical reagents and reference materials, plus Autoimmunity Systems anchored by the Complete Immunofluorescence Assay (IFA) System), Veterinary Analysis (vet-configured A15/BA200/BA400 biochemistry analysers and a vector-borne diseases ELISA line), Food & Beverage Analysis (SPICA, Y15, Y200, and Y400 analysers with dedicated reagents, including a 2024 AOAC-certified Gluten Analysis method and a methylcellulose Tannins Kit), Environmental Analysis of industrial wastewater and agricultural soils, and Bioprocess Analysis for monitoring sugars, organic acids, and nitrogenous substances. Supporting platforms include the eINFO documentation portal, Community Portal, External Applications Portal, and Cloud Platform.

The business model combines one-time instrument sales with recurring, usage-based revenue from proprietary reagents and reference materials tied to the installed analyser base — a classic razor-and-blade structure across regulated laboratory customers. The GTM motion is sales-led B2B with direct enterprise contact, distributed through 8 localized country websites covering Southern Europe (Spain, Italy), Western Europe (France), Latin America (Mexico, Chile), Eastern Europe (Romania), Southeast Asia (Philippines), and Western Asia (Türkiye), supported by LinkedIn and YouTube channels plus email/newsletter and product-finder content for funnel conversion. Pricing is quote-based and not publicly disclosed, consistent with mid-market enterprise IVD sales.

The company holds ISO 27001, IVDR compliance documentation, an EcoVadis certificate, and the AOAC Performance Tested Method certification for gluten analysis (license 072503). It is privately held with no disclosed institutional investors, funding rounds, M&A history, or leadership changes in the source material. The 2024 product cadence (IFA system launch, BA200/BA400 software v5.9.1, Y15 cover/software refresh, Tannins Kit, Gluten Analysis AOAC approval, and Anti-Babesia ELISA Dog Kit) indicates active R&D output across multiple segments in parallel.

Short descriptiontext

BioSystems S.A. is a Barcelona-based biotech company, founded in 1981, that designs, manufactures, and markets analytical instruments and reagent kits for in vitro diagnostics and industrial testing across clinical, veterinary, food & beverage, environmental, and bioprocess laboratories worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical biochemistry analysers, in vitro diagnostics reagents, veterinary diagnostic systems, food beverage analysis, bioprocess analytical solutions
Industry3 codes
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
In Vitro Diagnostics & Analytical Instruments
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Analytical Instrumentation Sales
TypeOne Time License
Description

Sale of analysers/instruments including BA200, BA400, A15, A15S for clinical use, and Y15, Y200, Y400, SPICA for food & beverage applications. One-time hardware purchase model.

biosystems.global
2Reagents & Consumables
TypeUsage Based
Description

Continuous revenue from reagent sales for analysers across all application areas (clinical, veterinary, food & beverage). Recurring consumption-based model tied to analyser installed base.

biosystems.global
3Reference Materials
TypeOne Time License
Description

Sale of reference materials for quality control and calibration across all analytical systems

biosystems.global
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Biochemistry Systems
Description

Analytical systems for biochemistry testing including analysers, reagents, and reference materials

biosystems.global
+3 more records
Core offering1 text field

BioSystems designs, develops, manufactures, and markets analytical instruments (analysers) and reagent kits for in vitro diagnostics (IVD), veterinary, food & beverage, environmental, and bioprocess applications. The offering combines proprietary hardware analysers (BA200, BA400, A15, A15S, Y15, Y200, Y400, SPICA) with application-specific reagents and reference materials, sold to laboratories and industrial customers across multiple countries.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

BioSystems is a biotech company that designs, develops, manufactures, and markets analytical solutions for in vitro diagnostics (IVD) laboratories and industrial purposes. The product portfolio consists of Clinical Analysis systems (Biochemistry Systems with BA400, BA200, A15, A15S analysers, reagents, and reference materials; Autoimmunity Systems with IFA System and reagents), Veterinary Analysis systems (Biochemistry Systems and Vector-borne Diseases Systems with dedicated analysers and reagents), Food & Beverage Analysis solutions (SPICA, Y15, Y200, Y400 analysers, Tannins Kit, Gluten Analysis System, reagents, and reference materials), Environmental Analysis services, and Bioprocess Analysis. Supporting platforms include eINFO, Community Portal, External Applications Portal, and Cloud Platform. The company has been operating since 1981.

Product and service1 record
1BA400 Clinical Biochemistry Analyser
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large Chinese medical device and IVD manufacturer producing clinical chemistry and immunoassay analysers and reagents. Comparable clinical chemistry analyser portfolio and emerging-market commercial strategy, but at substantially larger scale.

TypeDirect peer
Description

European manufacturer of analytical instruments and reagents for food, beverage, environmental, and clinical applications. Closely comparable in the food & beverage and environmental analysis product lines and analyser-plus-reagent economics.

TypeDirect peer
Description

Privately held European IVD and specialty diagnostics company manufacturing clinical chemistry analysers and reagents. Closely comparable mid-market position, similar product breadth (clinical chemistry, microbiology, industrial), and overlapping customer base in European clinical labs.

TypeBroad incumbent
Description

Large global analytical and measurement instrument manufacturer with significant presence in clinical, food, and environmental analysis. Comparable end markets and reagent-plus-instrument economics, but at much larger scale and broader portfolio.

TypeBroad incumbent
Description

Publicly listed life science and clinical diagnostics company with IVD reagents, quality controls, and immunology products. Overlaps with BioSystems in clinical chemistry reagents, autoimmune diagnostics, and reference materials.

TypeDirect peer
Description

Italian manufacturer of dedicated analytical instruments and reagents for food and beverage quality control. Comparable in the F&B analyser and reagent bundle, with overlapping wine and beverage customer segments.

TypeDirect peer
Description

Italian IVD company specialising in clinical chemistry, immunology, and autoimmunity reagents and analysers. Comparable in product mix (especially the autoimmune/IFA systems overlap) and mid-tier European commercial positioning.

TypeDirect peer
Description

Privately held IVD and clinical chemistry company manufacturing a broad portfolio of reagents, analysers, and quality control materials. Comparable vertical breadth (clinical, veterinary, food, environmental) and analyser-plus-reagent business model.

TypeDirect peer
Description

Mid-sized IVD manufacturer producing clinical chemistry and haematology analysers, reagents, and consumables. Directly comparable to BioSystems across instrument/reagent bundles, scale, and emerging-market commercial strategy.

10Agappe Diagnostics
TypeEmerging player
Description

India-based IVD reagents and analyser manufacturer serving emerging markets across clinical chemistry and immunology. Comparable mid-tier pricing tier and reagent-plus-instrument model targeted at cost-sensitive laboratory segments.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biosystems

In Vitro Diagnostics & Analytical Instrumentsbiosystems.global

BioSystems S.A. is a Barcelona-based biotech company, founded in 1981, that designs, manufactures, and markets analytical instruments and reagent kits for in vitro diagnostics and industrial testing across clinical, veterinary, food & beverage, environmental, and bioprocess laboratories worldwide.

What Biosystems does

BioSystems S.A. is a Barcelona-headquartered biotechnology company founded in 1981 that designs, develops, manufactures, and markets analytical instruments and reagent kits for in vitro diagnostics (IVD) and selected industrial applications. The portfolio is organized into five solution segments: Clinical Analysis (Biochemistry Systems using the BA400, BA200, A15, and A15S analysers together with clinical reagents and reference materials, plus Autoimmunity Systems anchored by the Complete Immunofluorescence Assay (IFA) System), Veterinary Analysis (vet-configured A15/BA200/BA400 biochemistry analysers and a vector-borne diseases ELISA line), Food & Beverage Analysis (SPICA, Y15, Y200, and Y400 analysers with dedicated reagents, including a 2024 AOAC-certified Gluten Analysis method and a methylcellulose Tannins Kit), Environmental Analysis of industrial wastewater and agricultural soils, and Bioprocess Analysis for monitoring sugars, organic acids, and nitrogenous substances. Supporting platforms include the eINFO documentation portal, Community Portal, External Applications Portal, and Cloud Platform.

The business model combines one-time instrument sales with recurring, usage-based revenue from proprietary reagents and reference materials tied to the installed analyser base — a classic razor-and-blade structure across regulated laboratory customers. The GTM motion is sales-led B2B with direct enterprise contact, distributed through 8 localized country websites covering Southern Europe (Spain, Italy), Western Europe (France), Latin America (Mexico, Chile), Eastern Europe (Romania), Southeast Asia (Philippines), and Western Asia (Türkiye), supported by LinkedIn and YouTube channels plus email/newsletter and product-finder content for funnel conversion. Pricing is quote-based and not publicly disclosed, consistent with mid-market enterprise IVD sales.

The company holds ISO 27001, IVDR compliance documentation, an EcoVadis certificate, and the AOAC Performance Tested Method certification for gluten analysis (license 072503). It is privately held with no disclosed institutional investors, funding rounds, M&A history, or leadership changes in the source material. The 2024 product cadence (IFA system launch, BA200/BA400 software v5.9.1, Y15 cover/software refresh, Tannins Kit, Gluten Analysis AOAC approval, and Anti-Babesia ELISA Dog Kit) indicates active R&D output across multiple segments in parallel.

Biosystems firmographics

Firmographics
Name
Biosystems
Legal name
BioSystems S.A.
Website
https://biosystems.global
Company type
Private
Founded year
1981
Operating status
Operating
Headcount range
501–1,000 employees
Short description
BioSystems S.A. is a Barcelona-based biotech company, founded in 1981, that designs, manufactures, and markets analytical instruments and reagent kits for in vitro diagnostics and industrial testing across clinical, veterinary, food & beverage, environmental, and bioprocess laboratories worldwide.
Ownership category
akta.pro rank

Biosystems industry classification

Industry
Product category
In Vitro Diagnostics & Analytical Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)

Keywords

  • Clinical biochemistry analysers
  • In vitro diagnostics reagents
  • Veterinary diagnostic systems
  • Food beverage analysis
  • Bioprocess analytical solutions

Where Biosystems is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Biosystems business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

Revenue model

  1. Analytical Instrumentation Sales: Sale of analysers/instruments including BA200, BA400, A15, A15S for clinical use, and Y15, Y200, Y400, SPICA for food & beverage applications. One-time hardware purchase model.
  2. Reagents & Consumables: Continuous revenue from reagent sales for analysers across all application areas (clinical, veterinary, food & beverage). Recurring consumption-based model tied to analyser installed base.
  3. Reference Materials: Sale of reference materials for quality control and calibration across all analytical systems

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Biosystems product offering

Product offering

Core offering

BioSystems designs, develops, manufactures, and markets analytical instruments (analysers) and reagent kits for in vitro diagnostics (IVD), veterinary, food & beverage, environmental, and bioprocess applications. The offering combines proprietary hardware analysers (BA200, BA400, A15, A15S, Y15, Y200, Y400, SPICA) with application-specific reagents and reference materials, sold to laboratories and industrial customers across multiple countries.

Product overview

BioSystems is a biotech company that designs, develops, manufactures, and markets analytical solutions for in vitro diagnostics (IVD) laboratories and industrial purposes. The product portfolio consists of Clinical Analysis systems (Biochemistry Systems with BA400, BA200, A15, A15S analysers, reagents, and reference materials; Autoimmunity Systems with IFA System and reagents), Veterinary Analysis systems (Biochemistry Systems and Vector-borne Diseases Systems with dedicated analysers and reagents), Food & Beverage Analysis solutions (SPICA, Y15, Y200, Y400 analysers, Tannins Kit, Gluten Analysis System, reagents, and reference materials), Environmental Analysis services, and Bioprocess Analysis. Supporting platforms include eINFO, Community Portal, External Applications Portal, and Cloud Platform. The company has been operating since 1981.

Differentiator

Problem solved

Functional benefit

Brands

  • Biochemistry Systems: Analytical systems for biochemistry testing including analysers, reagents, and reference materials
  • Autoimmunity Systems
  • Vector-borne Diseases Systems
  • IFA System

Products and services

  • BA400 Clinical Biochemistry Analyser

Companies that use Biosystems

Customer profile

Segments5 records

Ideal customer profiles4 records

Biosystems technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Biosystems partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights6 records

Biosystems competitors and assessment

Company assessment

Broad incumbents

  • Mindray: Large Chinese medical device and IVD manufacturer producing clinical chemistry and immunoassay analysers and reagents. Comparable clinical chemistry analyser portfolio and emerging-market commercial strategy, but at substantially larger scale.
  • HORIBA: Large global analytical and measurement instrument manufacturer with significant presence in clinical, food, and environmental analysis. Comparable end markets and reagent-plus-instrument economics, but at much larger scale and broader portfolio.
  • Bio-Rad Laboratories: Publicly listed life science and clinical diagnostics company with IVD reagents, quality controls, and immunology products. Overlaps with BioSystems in clinical chemistry reagents, autoimmune diagnostics, and reference materials.

Direct peers

  • AMS Alliance: European manufacturer of analytical instruments and reagents for food, beverage, environmental, and clinical applications. Closely comparable in the food & beverage and environmental analysis product lines and analyser-plus-reagent economics.
  • ELITech Group: Privately held European IVD and specialty diagnostics company manufacturing clinical chemistry analysers and reagents. Closely comparable mid-market position, similar product breadth (clinical chemistry, microbiology, industrial), and overlapping customer base in European clinical labs.
  • CDR FoodLab: Italian manufacturer of dedicated analytical instruments and reagents for food and beverage quality control. Comparable in the F&B analyser and reagent bundle, with overlapping wine and beverage customer segments.
  • DIESSE Diagnostica: Italian IVD company specialising in clinical chemistry, immunology, and autoimmunity reagents and analysers. Comparable in product mix (especially the autoimmune/IFA systems overlap) and mid-tier European commercial positioning.
  • Randox Laboratories: Privately held IVD and clinical chemistry company manufacturing a broad portfolio of reagents, analysers, and quality control materials. Comparable vertical breadth (clinical, veterinary, food, environmental) and analyser-plus-reagent business model.
  • Erba Mannheim: Mid-sized IVD manufacturer producing clinical chemistry and haematology analysers, reagents, and consumables. Directly comparable to BioSystems across instrument/reagent bundles, scale, and emerging-market commercial strategy.

Emerging players

  • Agappe Diagnostics: India-based IVD reagents and analyser manufacturer serving emerging markets across clinical chemistry and immunology. Comparable mid-tier pricing tier and reagent-plus-instrument model targeted at cost-sensitive laboratory segments.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Biosystems social profiles

Digital presence

Biosystems compliance and trust

Trust signal

Compliance4 records

Biosystems financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biosystems leadership team

Management profile

Number of profiles

Biosystems funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biosystems M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biosystems

What does Biosystems do?

BioSystems designs, develops, manufactures, and markets analytical instruments (analysers) and reagent kits for in vitro diagnostics (IVD), veterinary, food & beverage, environmental, and bioprocess applications. The offering combines proprietary hardware analysers (BA200, BA400, A15, A15S, Y15, Y200, Y400, SPICA) with application-specific reagents and reference materials, sold to laboratories and industrial customers across multiple countries.

Is Biosystems a public or private company?

Biosystems is a private company. It is classified as unknown and is currently operating.

When was Biosystems founded?

Biosystems was founded in 1981. It employs 501 to 1,000 people.

Where is Biosystems based?

Biosystems is headquartered in Barcelona, Spain, in the Europe region.

How does Biosystems make money?

Three revenue lines are on record. Analytical Instrumentation Sales are the primary driver. The others are reagents & Consumables and reference Materials.

Who are Biosystems's main competitors?

Broad incumbents on record are Mindray, HORIBA and Bio-Rad Laboratories. Direct peers are AMS Alliance, ELITech Group, CDR FoodLab, DIESSE Diagnostica, Randox Laboratories and Erba Mannheim. Agappe Diagnostics is listed as an emerging player.

Does Biosystems have an API?

No public API is recorded for Biosystems.

What industry is Biosystems in?

Biosystems's product category is In Vitro Diagnostics & Analytical Instruments. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales